Nalagenetics
PrivateLast Round
Series A
Mar 25, 2022
Total Funding Raised
$13.6M
Company Overview
Nalagenetics operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in March 2022.
Nalagenetics is a biotechnology company that provides genetic testing and clinical decision support software to enable personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nalagenetics Comparables
Compare Nalagenetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qiagen | 79% | |
| Geneyx | 77% | |
| Aranscia | 77% |
For institutional investors. Book with your work email.
Nalagenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 25, 2022 | ||||
| Pre Seed | Nov 1, 2018 |
For institutional investors. Book with your work email.
Nalagenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Intudo Ventures | Pre Seed, Series A |
| AngelCentral | Pre Seed |
| Integra Partners | Series A |
| Accelerate Technologies Pte Ltd | Series A |
| Vulcan Capital | Series A |
| East Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 49% MoM, reaching 6.4K.
- Jul 24, 2023
Grew 20% QoQ, from 80 to 96 employees.
For institutional investors. Book with your work email.
Nalagenetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nalagenetics's valuation, stock price, and market status.
Is Nalagenetics a public or private company?
Nalagenetics is a private company.
What is the current stock price of Nalagenetics?
Nalagenetics is a private company, so its shares have no public market price. Caplight tracks Nalagenetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nalagenetics worth (valuation)?
Valuation information for Nalagenetics is not publicly available.
Can I buy Nalagenetics stock?
Nalagenetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nalagenetics's last funding round?
Nalagenetics's most recent funding round was Series A on March 25, 2022.
Who are the main investors in Nalagenetics?
Key investors in Nalagenetics include Intudo Ventures, Vulcan Capital, East Ventures.
Will Nalagenetics IPO soon?
No public IPO plans have been announced for Nalagenetics.
How can I track Nalagenetics secondary market activity?
Caplight tracks bids, offers, and trades in Nalagenetics's shares on secondary markets.